Physio‐Contro (@PhysioControl) and BeneChill (@RhinoChill) announced today a strategic partnership to launch the RhinoChill IntraNasal Cooling System in Europe. RhinoChill is a non‐invasive, portable system for transnasally cooling the head and lowering the body’s core temperature immediately following cardiac arrest, stroke or traumatic brain injury.
Initially, the partnership will focus on bringing the RhinoChill System to market in the United Kingdom, Germany, Austria, Switzerland, Belgium, Netherlands and Luxemburg during the first quarter of 2011, utilizing Physio‐Control’s extensive European distribution network. Additionally, as part of this strategic alliance, the two companies will work jointly to develop additional applications for BeneChill and work towards making the RhinoChill System available in the U.S.
The RhinoChill System uses a non‐invasive nasal catheter that sprays a rapidly evaporating, inert coolant liquid into the nasal cavity, a large area situated beneath the brain that acts as a heat exchanger. As the liquid evaporates, heat is directly removed from the base of the skull and surrounding tissues via conduction and indirectly through the blood via convection.
The system is battery‐powered, compact and does not require refrigeration, making it ideal for use in pre‐hospital settings. Each coolant bottle holds enough liquid to cool a patient for 30 minutes at nominal flow, and bottles can be easily exchanged to maintain the cooling process.
I’ve got to admit that this technology looks interesting. I’d like to see how it stacks up against iced saline and external cooling (which is pretty inexpensive).
This blog post derived in part from a press release by Physio-Control with whom Tom Bouthillet and the EMS 12-Lead blog have no conflict of interest.